Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Constellation Pharmaceuticals Inc (CNST)

Constellation Pharmaceuticals Inc (CNST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,216,841
  • Shares Outstanding, K 41,989
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,550 K
  • 60-Month Beta 3.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.82
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.92
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.66
  • Number of Estimates 6
  • High Estimate -0.61
  • Low Estimate -0.70
  • Prior Year -0.80
  • Growth Rate Est. (year over year) +17.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.69 +4.66%
on 06/30/20
40.84 -29.04%
on 06/15/20
-8.98 (-23.66%)
since 06/02/20
3-Month
27.69 +4.66%
on 06/30/20
50.90 -43.06%
on 05/12/20
-1.02 (-3.40%)
since 04/02/20
52-Week
6.01 +382.20%
on 09/30/19
59.49 -51.29%
on 12/09/19
+18.81 (+184.96%)
since 07/02/19

Most Recent Stories

More News
Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has...

JPM : 92.66 (+0.32%)
CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock

Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has...

JPM : 92.66 (+0.32%)
CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise

-- Spleen response rates in first-line patients at 12 weeks and 24 weeks in line with previously reported data and differentiated from standard of care

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals to Participate in Investor Conference

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company...

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jeffrey Humphrey, M.D.,...

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals to Participate in Investor Conference

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company...

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a virtual analyst/investor...

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals, Inc. (CNST) Upgraded to Buy: What Does It Mean for the Stock?

Constellation Pharmaceuticals, Inc. (CNST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CNST : 28.98 (+0.52%)
Is Constellation (CNST) Stock a Solid Choice Right Now?

Constellation (CNST) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

CNST : 28.98 (+0.52%)
Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts

-- Continued high rate of SVR35 in 1L patients: 72% at 12 weeks and 67% at 24 weeks

CNST : 28.98 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CNST with:

Business Summary

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and...

See More

Key Turning Points

2nd Resistance Point 30.28
1st Resistance Point 29.63
Last Price 28.98
1st Support Level 28.25
2nd Support Level 27.52

See More

52-Week High 59.49
Fibonacci 61.8% 39.06
Fibonacci 50% 32.75
Last Price 28.98
Fibonacci 38.2% 26.44
52-Week Low 6.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar